David Hakimian
Advanced in Gaucher Disease Type 2

Dr. David Hakimian

Hematology | Oncology
8915 W Golf Rd 4th Fl, 
Niles, IL 
On Staff At
Advanced in Gaucher Disease Type 2
8915 W Golf Rd 4th Fl, 
Niles, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Hakimian is a Hematologist and an Oncologist in Niles, Illinois. Dr. Hakimian is rated as an Advanced provider by MediFind in the treatment of Gaucher Disease Type 2. His top areas of expertise are Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 25 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
Advocate Lutheran General Hospital, Internal Medicine
Specialties
Hematology
Oncology
Licenses
Internal Medicine in IL
Board Certifications
American Board Of Internal Medicine, Hematology
Fellowships
Northwestern University, Hematology/Oncology
Hospital Affiliations
Advocate Lutheran General Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Illinois Cancer Specialists
8915 W Golf Rd 4th Fl, Niles, IL 60714

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants Whose Disease Has Remained Stable or Responded to First-Line Platinum -Based Chemotherapy With Pembrolizumab for Stage IIIB/IIIC or IV Non-Small Cell Lung Cancer (ZEAL-1L)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants Whose Disease Has Remained Stable or Responded to First-Line Platinum -Based Chemotherapy With Pembrolizumab for Stage IIIB/IIIC or IV Non-Small Cell Lung Cancer (ZEAL-1L)
Enrollment Status: Active_not_recruiting
Publish Date: September 29, 2025
Intervention Type: Biological, Drug
Study Drugs: Niraparib, Pembrolizumab
Study Phase: Phase 3
A Phase 2 Study of Avutometinib (VS-6766) (Dual RAF/MEK Inhibitor) as a Single Agent and In Combination With Defactinib (FAK Inhibitor) in Recurrent KRAS-Mutant (KRAS-MT) and BRAF-Mutant (BRAF-MT) Non-Small Cell Lung Cancer (NSCLC) (RAMP 202)
A Phase 2 Study of Avutometinib (VS-6766) (Dual RAF/MEK Inhibitor) as a Single Agent and In Combination With Defactinib (FAK Inhibitor) in Recurrent KRAS-Mutant (KRAS-MT) and BRAF-Mutant (BRAF-MT) Non-Small Cell Lung Cancer (NSCLC) (RAMP 202)
Enrollment Status: Completed
Publish Date: January 12, 2024
Intervention Type: Drug
Study Drugs: VS-6766, VS-6766+Defactinib
Study Phase: Phase 2
A Phase 1/2 Study of Pegzilarginase (AEB1102, Co-ArgI-PEG) in Combination With Pembrolizumab in the Treatment of Patients With Extensive Disease (ED) Small Cell Lung Cancer (SCLC)
A Phase 1/2 Study of Pegzilarginase (AEB1102, Co-ArgI-PEG) in Combination With Pembrolizumab in the Treatment of Patients With Extensive Disease (ED) Small Cell Lung Cancer (SCLC)
Enrollment Status: Completed
Publish Date: November 04, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

24 Total Publications

Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network's MYLUNG Consortium.
Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network's MYLUNG Consortium.
Journal: Journal of the advanced practitioner in oncology
Published: January 13, 2025
Similar Doctors
Advanced in Gaucher Disease Type 2
Dr. Ira A. Oliff
Hematology Oncology | Hematology | Oncology
Advanced in Gaucher Disease Type 2
Dr. Ira A. Oliff
Hematology Oncology | Hematology | Oncology
9711 Skokie Blvd, Ste A, 
Skokie, IL 
 (5.3 miles away)
847-568-9930
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ira Oliff is a Hematologist Oncology specialist and a Hematologist in Skokie, Illinois. Dr. Oliff is rated as a Distinguished provider by MediFind in the treatment of Gaucher Disease Type 2. His top areas of expertise are Waldenstrom Macroglobulinemia, Lung Cancer, Colorectal Cancer, and Childhood Iron Deficiency Anemia. Dr. Oliff is currently accepting new patients.

Sonia Christian
Experienced in Gaucher Disease Type 2
Dr. Sonia Christian
Hematology | Oncology
Experienced in Gaucher Disease Type 2
Dr. Sonia Christian
Hematology | Oncology

Advocate Medical Group Oncology

900 W Nelson St Ground Fl, 
Chicago, IL 
 (13.0 miles away)
773-296-7089
Languages Spoken:
English
See accepted insurances

Sonia Christian is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Christian is rated as an Experienced provider by MediFind in the treatment of Gaucher Disease Type 2. Her top areas of expertise are Thrombocytopenia, Gallbladder Adenocarcinoma, Gallbladder Cancer, Pulmonary Embolism, and Bone Marrow Aspiration.

Advanced in Gaucher Disease Type 2
Dr. Lynne S. Kaminer
Hematology
Advanced in Gaucher Disease Type 2
Dr. Lynne S. Kaminer
Hematology

Endeavor Health Medical Group

2650 Ridge Ave, 
Evanston, IL 
 (8.5 miles away)
Experience:
43+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lynne Kaminer is a Hematologist in Evanston, Illinois. Dr. Kaminer has been practicing medicine for over 43 years and is rated as a Distinguished provider by MediFind in the treatment of Gaucher Disease Type 2. Her top areas of expertise are Non-Hodgkin Lymphoma, Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Kaminer is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hakimian's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 31 Advanced Conditions
    View All 145 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile